These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7577197)

  • 1. Special issues that arise in applying techniques of economic analysis to evaluation of cancer therapies.
    Weeks JC
    J Natl Cancer Inst Monogr; 1995; (19):11-2. PubMed ID: 7577197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.
    Evans WK; Coyle D; Gafni A; Walker H;
    Chronic Dis Can; 2003; 24(4):102-7. PubMed ID: 14733759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analyses of clinical trials in cancer: are they helpful to policy makers?
    Bennett CL; Armitage JL; LeSage S; Gulati SC; Armitage JO; Gorin NC
    Stem Cells; 1994 Jul; 12(4):424-9. PubMed ID: 7951008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperatives.
    Anderson BD; Adamson PC; Weiner SL; McCabe MS; Smith MA
    J Clin Oncol; 2004 Dec; 22(23):4846-50. PubMed ID: 15570088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking quality of life into account in health economic analyses.
    Weeks J
    J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Funding patient-reported outcomes in cancer clinical trials.
    Moinpour CM; Denicoff AM; Bruner DW; Kornblith AB; Land SR; O'Mara A; Trimble E
    J Clin Oncol; 2007 Nov; 25(32):5100-5. PubMed ID: 17991928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS). Office of the Secretary, DoD. Notice of expansion of cancer treatment clinical trials demonstration project.
    Fed Regist; 1999 Jun; 64(109):30490-1. PubMed ID: 10558567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medical therapies for children with cancer.
    Kelly KM
    Eur J Cancer; 2004 Sep; 40(14):2041-6. PubMed ID: 15341976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliation and supportive care in radiation medicine.
    Janjan N
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):187-211. PubMed ID: 16580563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring costs: administrative claims data, clinical trials, and beyond.
    Etzioni R; Riley GF; Ramsey SD; Brown M
    Med Care; 2002 Jun; 40(6 Suppl):III63-72. PubMed ID: 12064760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
    Meyers FJ; Linder J; Beckett L; Christensen S; Blais J; Gandara DR
    J Pain Symptom Manage; 2004 Dec; 28(6):548-56. PubMed ID: 15589080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.